A detailed history of Biltmore Family Office, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Biltmore Family Office, LLC holds 3,293 shares of LLY stock, worth $2.59 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
3,293
Previous 3,005 9.58%
Holding current value
$2.59 Million
Previous $2.72 Million 7.24%
% of portfolio
0.52%
Previous 0.51%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $222,376 - $276,485
288 Added 9.58%
3,293 $2.92 Million
Q2 2024

Aug 07, 2024

BUY
$724.87 - $909.04 $58,714 - $73,632
81 Added 2.77%
3,005 $2.72 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $33,906 - $46,745
-78 Reduced 2.6%
2,924 $1.57 Million
Q2 2023

Aug 07, 2023

SELL
$350.74 - $468.98 $24,201 - $32,359
-69 Reduced 2.25%
3,002 $1.41 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $16,152 - $18,970
52 Added 1.72%
3,071 $1.05 Million
Q4 2022

Feb 07, 2023

SELL
$321.55 - $374.67 $29,582 - $34,469
-92 Reduced 2.96%
3,019 $1.1 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $1,185 - $1,351
4 Added 0.13%
3,111 $1.01 Million
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $661,426 - $776,611
-2,373 Reduced 43.3%
3,107 $1.01 Million
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $348,517 - $432,512
1,550 Added 39.44%
5,480 $1.51 Million
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $3,391 - $4,488
-26 Reduced 0.66%
3,930 $664,000
Q1 2020

May 08, 2020

SELL
$119.05 - $147.35 $3,928 - $4,862
-33 Reduced 0.83%
3,956 $549,000
Q4 2019

Feb 05, 2020

BUY
$106.92 - $132.43 $20,635 - $25,558
193 Added 5.08%
3,989 $524,000
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $148,260 - $166,096
-1,400 Reduced 26.94%
3,796 $439,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $425,760 - $456,676
5,196
5,196 $439,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $746B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Biltmore Family Office, LLC Portfolio

Follow Biltmore Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Biltmore Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Biltmore Family Office, LLC with notifications on news.